Destroyed lung due to sustained inflammation after chemoradiotherapy followed by durvalumab
Author:
Affiliation:
1. Department of Respiratory MedicineHirosaki University Graduate School of Medicine Hirosaki Japan
2. Department of Anatomic PathologyHirosaki University Graduate School of Medicine Hirosaki Japan
Publisher
Wiley
Subject
Pulmonary and Respiratory Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/rcr2.580
Reference5 articles.
1. Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer
2. Acute progression of aspergillosis in a patient with lung cancer receiving nivolumab;Uchida N;Respirol. Case Rep.,2017
3. Invasive aspergillosis in a patient with stage III (or 3a or 3b) non‐small‐cell lung cancer treated with durvalumab;Gupta A;Case Rep. Oncol. Med.,2019
4. Emerging concerns of infectious diseases in lung cancer patients receiving immune checkpoint inhibitor therapy
5. Anti–PD-1 Antibody Treatment and the Development of Acute Pulmonary Tuberculosis
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Infectious Complications in Patients With Non-small Cell Lung Cancer Treated With Immune Checkpoint Inhibitors;Clinical Lung Cancer;2023-11
2. Opportunistic Infections and Immune-Related Adverse Events Associated with Administering Immune Checkpoint Inhibitors: A Narrative Review;Pharmaceuticals;2023-08-09
3. Necrotizing pneumonia due to Aspergillus and Salmonella after immune checkpoint inhibitor treatment: An unusual case and review of the literature;Revista Iberoamericana de Micología;2023-04
4. Infectious Complications of Targeted Therapies for Solid Cancers or Leukemias/Lymphomas;Cancers;2023-03-27
5. A case of non-neutropenic invasive pulmonary aspergillosis under immune checkpoint inhibitor therapy for malignant melanoma;Respiratory Medicine Case Reports;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3